Skip Navigation

European Heart Journal 2005 26(22):2395; doi:10.1093/eurheartj/ehi518
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Papavassiliu, T.
Right arrow Articles by Borggrefe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papavassiliu, T.
Right arrow Articles by Borggrefe, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis

Theano Papavassiliu1,*, Philipp Schnabel2, Meike Schröder3 and Martin Borggrefe1

1I. Medical Department, University Hospital Mannheim, 68167 Mannheim, Germany
2Department of Pathology, University Heidelberg, Heidelberg, Germany
3Department of Radiology, University Hospital Mannheim, 68167 Mannheim, Germany

* Corresponding author. Tel: +49 621 3832512; fax: +49 621 3832012. E-mail address: theano.papavassilliu{at}med.ma.uni-heidelberg.de

A 38-year-old female patient with hypertrophic cardiomyopathy and congestive heart failure underwent late gadolinium enhancement cardiovascular magnetic resonance (CMR). Cine CMR (Panel A) revealed normal dimensions of the left ventricle (left ventricular end-diastolic diameter 45 mm) with moderately reduced left ventricular systolic function (ejection fraction 40%). The maximum wall thickness was 16 mm and there was severe dilation of both atria. Using a T1-weighted inversion-recovery sequence 15 min after the application of 0.2 mmol/kg body weight gadolinium-DTPA, the anteroseptal, inferoseptal, and the anterior walls (Panel B) of the left ventricle showed extensive regions of myocardial enhancement. During her hospital course, the patient developed malignant ventricular arrhythmias and underwent urgent heart transplantation 30 days after the CMR scan. The explanted heart was examined histologically for the extent of fibrosis and disarray. The macroscopic examination of the explanted heart showed massive scarring. Microscopy showed areas of myofibril disarray and scars. These findings were diagnostic of HCM. Regions of gadolinium enhancement correlate well with regions of macroscopic pale myocardium (Panel C) and regions of fibrosis (Panel D).

Panel A. Pre-contrast diastolic long-axis cine image in vivo obtained with cine CMR.

Panel B. Post-contrast image demonstrating myocardial hyperenhancement in vivo. There is a large area of mid-myocardial late gadolinium enhancement of the anterior wall (arrows).

Panel C. Corresponding gross specimen from the explanted heart with well-defined regions of macroscopic mid-myocardial pale myocardium similar to the distribution of late gadolinium enhancement in Panel B.

Panel D. Histological section (haematoxylin and eosin stain) shows a magnification of the box in Panel C with pronounced fibrosis (sheets of collagen stained pink). There is a concordance between regions of gadolinium enhancement in vivo and regions of fibrotic tissue.


{ehi51801}


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
M. Michels, O. I.I. Soliman, J. Phefferkorn, Y. M. Hoedemaekers, M. J. Kofflard, D. Dooijes, D. Majoor-Krakauer, and F. J. Ten Cate
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
Eur. Heart J., November 1, 2009; 30(21): 2593 - 2598.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici
The case for myocardial ischemia in hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol., August 25, 2009; 54(9): 866 - 875.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Rudolph, H. Abdel-Aty, S. Bohl, P. Boye, A. Zagrosek, R. Dietz, and J. Schulz-Menger
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
J. Am. Coll. Cardiol., January 20, 2009; 53(3): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
M. S. Maron, E. Appelbaum, C. J. Harrigan, J. Buros, C. M. Gibson, C. Hanna, J. R. Lesser, J. E. Udelson, W. J. Manning, and B. J. Maron
Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
Circ Heart Fail, September 1, 2008; 1(3): 184 - 191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. W. Hansen and N. Merchant
MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances
Am. J. Roentgenol., December 1, 2007; 189(6): 1335 - 1343.
[Abstract] [Full Text] [PDF]


This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Papavassiliu, T.
Right arrow Articles by Borggrefe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papavassiliu, T.
Right arrow Articles by Borggrefe, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?